Invio, Inc.

About:

Invio is a cloud-based automation of clinical trial data quality monitoring.

Website: https://invioinc.com/

Twitter/X: invioinc

Top Investors: Techstars, Cedars-Sinai Accelerator, Right Side Capital Management, Pipeline Angels, Seattle Angel Conference

Description:

For clinical trials, monitoring the accuracy of data collected from each hospital in the trial is essential and required by FDA. To achieve this today, those monitoring the trial visit each hospital frequently in person to review any newly collected data. Costs associated with this account for a third of clinical operations costs. Invio provides a cloud-based platform for managing this data quality control process from anywhere, flagging potential problems automatically. We help ensure the right subjects are enrolled in the trial, the data being recorded is correct, and healthcare professionals are making the best use of their time. The result? Clinical trials are faster, easier, and cheaper to run.

Total Funding Amount:

$660000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2016-04-08

Contact Email:

hello(AT)invioinc.com

Founders:

Brian Caruso, Cassie Wallender

Number of Employees:

1-10

Last Funding Date:

2017-09-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai